Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2015-01-08 11:27 (3389 d 10:21 ago) – Posting: # 14251
Views: 27,912

Dear Cher!

❝ Sorry to ask again, but I can't see any contradiction between point 1 and 3.


Once again slowly to take notes:
Suppose you have a subject with two periods absolved, in both Reference applied.
According to your rules, point 1, you don't have at least one Reference and one Test applied, so you will not include such a subject in the pharmacokinetic and statistical analysis.
Full stop.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,661 registered users;
88 visitors (0 registered, 88 guests [including 5 identified bots]).
Forum time: 22:49 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5